EPISODE · Jun 3, 2019 · 56 MIN
U2FP CureCast Episode 31: Conversation with EStand trial participants Kathy Allen and Sandra Mulder
from U2FP CureCast · host Matthew Rodreick & Jason Stoffer
Matthew and Kate talk with Kathy Allen and Sandra Mulder, the first two participants in the EStand Trial in Minnesota. Kathy and Sandra (as well as Jered Chinook who participated in the Mayo Clinic’s Epidural Stimulation study) were invited to attend the American Spinal Injury Association Conference in April to share their personal experiences as part of a conversation facilitated by U2FP’s Executive Director, Matthew Rodreick. We thought it would be helpful to hear from them directly on the podcast. We talk about their early experiences in the trial, where they are now, and what they continue to experience. It’s a nice follow up to the Epsiode #30 interview with Dr. David Darrow, the principal investigator of the EStand trial. If you haven’t listened to that one, check it out to fill in all the information.
What this episode covers
Matthew and Kate talk with Kathy Allen and Sandra Mulder, the first two participants in the EStand Trial in Minnesota. Kathy and Sandra (as well as Jered Chinook who participated in the Mayo Clinic’s Epidural Stimulation study) were invited to attend the American Spinal Injury Association Conference in April to share their personal experiences as part of a conversation facilitated by U2FP’s Executive Director, Matthew Rodreick. We thought it would be helpful to hear from them directly on the podcast. We talk about their early experiences in the trial, where they are now, and what they continue to experience. It’s a nice follow up to the Epsiode #30 interview with Dr. David Darrow, the principal investigator of the EStand trial. If you haven’t listened to that one, check it out to fill in all the information.
NOW PLAYING
U2FP CureCast Episode 31: Conversation with EStand trial participants Kathy Allen and Sandra Mulder
No transcript for this episode yet
Similar Episodes
Jan 22, 2021 ·3m
Jan 20, 2021 ·30m
Jan 11, 2021 ·18m
Jan 10, 2021 ·0m
Mar 2, 2019 ·1m